Incidence and surgical outcomes of patients with native and prosthetic aortic valve endocarditis.
The aim of this study was to retrospectively evaluate the incidence and surgical outcomes of patients with native infective (IE) and prosthetic (PVE) aortic valve endocarditis during the past decade at a single institution. Between 01/2005-12/2015, 289 patients (mean age 63.3±14.2yrs) suffering from native IE (n=186) and PVE (n=103) of the aortic valve were operated. Perioperative data was acquired retrospectively for statistical analysis. During the study period, the mean incidence of endocarditis increased from 22.0±4.2 (2005-2009) to 29.8±10.1 (2010-2015) cases/year. In-hospital mortality was significantly increased in PVE vs. IE patients: 22.3% vs. 9.1% (p<.001). In elective cases, in-hospital mortality between the two groups was comparable (2.2% vs. 4.6%;p=.288). Multivariate analysis identified "urgent surgery" (OR: 6.461; 95%-CI:1.941-21.509;p=.002), "mitral regurgitation II" (OR: 4.230; 95%-CI:1.249-14.331;p=.021), "previous homograft operation" (OR: 66.096; 95%-CI:2.369-1844.272;p=.0.14) and "LVEF <40%" (OR 8.267; 95%-CI:1.931-35.388;p=.004) as independent risk factors for in-hospital mortality, while pathogen identification by "preoperative blood cultures" (OR: .228; 95%-CI:.063-.817;p=.023) was found to be independently protective. Surgery for native IE and PVE of the aortic valve may be performed with satisfactorily results at experienced cardiac surgical centers. In comparison, PVE patients suffer from a more than twice as high in-hospital mortality, more postoperative complications and inferior long-term survival. However, preoperative identification of causative pathogens in IE and PVE allows for improved in-hospital survival.